Back to Search Start Over

Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis

Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis

Authors :
Maryam Shayesteh Alam
Brittanie LaBelle
Source :
JAAD Case Reports, Vol 6, Iss 3, Pp 219-221 (2020), JAAD Case Reports
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Adalimumab (Humira; Abbott Laboratories, Puerto Rico) is a recombinant human IgG1 monoclonal antibody for tumor necrosis factor and is a treatment option for both hidradenitis suppurativa (HS) and rheumatoid arthritis (RA). We report a case of a patient with lichen planopilaris (LPP) that had hair regrowth when treated with adalimumab, originally prescribed to the patient for RA and HS.

Details

ISSN :
23525126
Volume :
6
Database :
OpenAIRE
Journal :
JAAD Case Reports
Accession number :
edsair.doi.dedup.....49286a4b2051c7b324e1e3b16f865488
Full Text :
https://doi.org/10.1016/j.jdcr.2019.12.016